Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant ...

One university graduate said America "is losing scientific talent because of this broad, systematic attack on science funding ...

Protein degradation company Plexium has laid off staff as part of a realignment to support the company’s pipeline, which is ...

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it has been awarded a contract from Aspera Biomedicines, Inc. (Aspera), a ...

Tijuana has long been recognized as an important hub of manufacturing and production in the San Diego-Tijuana binational ...

Members of the Artiva management team will also be available to participate in investor meetings with investors who are registered to attend the conference. Investors and the general public are ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

A San Diego biotech company is helping top research labs develop mRNA vaccines, including a vaccine for some types of cancer. Jaime Chambers reports. STORY: fox5sandiego.com Dutch government ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

Regeneron Pharmaceuticals is purchasing genetics and biotechnology ... to a 23andMe blog. The company was based in Sunnyvale, California, with another location in San Francisco.